-+ 0.00%
-+ 0.00%
-+ 0.00%

Guangzhou Chantou portfolio firm Ruitai Bio wins China National Technological Invention Award second prize

PUBT·07/23/2026 02:07:28
Listen to the news
Guangzhou Chantou portfolio firm Ruitai Bio wins China National Technological Invention Award second prize
  • Guangzhou Industry Investment Holding Group portfolio company Ruitai Bio won a 2025 National Technological Invention Award, second class, for corneal donor substitute technology.
  • The project developed corneal repair products to address donor shortages; flagship wet bio-amniotic membrane Ruixiufu has treated about 100,000 eyes since 2020.
  • Ruitai Bio’s Ruixiukang, a sutureless soft bio-amniotic membrane, entered China’s innovative medical device green channel in October 2025.
  • Guangzhou Industry Investment Holding Group-backed Kechuang Zhihui No. 1 Fund participated in Ruitai Bio’s Series A financing in 2022.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Industry Investment Holding Group Co Ltd published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.